Loading company…
Norwich Pharmaceuticals, Inc. develops, manufactures and markets complex generic and branded medications from Norwich, US.
Its portfolio includes more than 50 products, such as complex inhalation therapies and 505(b)(2) products, distributed across the US, Europe and other markets. Founded in Norwich, US, the company was acquired by AFI Partners in August 2007, with terms not disclosed. It is recorded at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in